TBIO (OTC)
TELESIS BIO INC
$0.055000
+0.000000 (+0.00%)
Prev close: $0.055000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ronald C. Renaud, Jr., MBA
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $2,823.92M
- Employees
- —
- P/E (TTM)
- 74.36
- P/B (TTM)
- 6.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q3)
|
$-3.83 | $-6.71 | +2.8816 | +42.93% |
|
Jun 2024 (Q2)
|
$-7.62 | $-4.11 | -3.5094 | -85.37% |
|
Mar 2024 (Q1)
|
$-5.52 | $-4.22 | -1.2972 | -30.72% |
|
Dec 2023 (Q4)
|
$-4.14 | $-4.04 | -0.1008 | -2.50% |
Financial Statements
| Revenues | $22.80M |
| Benefits Costs and Expenses | $24.05M |
| Cost Of Revenue | $12.58M |
| Costs And Expenses | $24.05M |
| Gross Profit | $10.22M |
| Operating Expenses | $12.30M |
| Operating Income/Loss | -$2.08M |
| Income/Loss From Continuing Operations After Tax | -$1.25M |
| Income/Loss From Continuing Operations Before Tax | -$1.25M |
| Net Income/Loss | -$1.25M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.25M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.25M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.81 |
| Diluted Earnings Per Share | -$0.81 |
| Basic Average Shares | 1,560,889 |
| Diluted Average Shares | 1,560,889 |
| Assets | $21.15M |
| Current Assets | $5.67M |
| Inventory | $788.00K |
| Other Current Assets | $4.88M |
| Noncurrent Assets | $15.49M |
| Fixed Assets | $771.00K |
| Intangible Assets | $11.16M |
| Other Non-current Assets | $3.56M |
| Liabilities | $7.40M |
| Current Liabilities | $4.45M |
| Accounts Payable | $1.14M |
| Wages | $1.42M |
| Other Current Liabilities | $1.90M |
| Noncurrent Liabilities | $2.95M |
| Equity | $13.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.75M |
| Liabilities And Equity | $21.15M |
| Net Cash Flow From Operating Activities | $884.00K |
| Net Cash Flow From Operating Activities, Continuing | $884.00K |
| Net Cash Flow From Investing Activities | -$295.00K |
| Net Cash Flow From Investing Activities, Continuing | -$295.00K |
| Net Cash Flow From Financing Activities | $663.00K |
| Net Cash Flow From Financing Activities, Continuing | $663.00K |
| Net Cash Flow | $1.25M |
| Net Cash Flow, Continuing | $1.25M |
| Comprehensive Income/Loss | -$1.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.25M |
| Other Comprehensive Income/Loss | $0.00 |